Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone via Nasopore for Early Nasal Polyposis
NCT01222871Phase 2Terminated
- Sponsor
- St. Elizabeth's Medical Center
- Start
- Jul 2010
- Primary completion
- Jul 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of triamcinolone in nasal polyps, sponsored by St. Elizabeth's Medical Center. Started Jul 2010; status: terminated.
02
Drugs
triamcinolone
03
Conditions
nasal polyps
Beyond the preview
Go deeper on NCT01222871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01222871.